Clinical Trial

New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs

Study acronym: ADENO-MIRNA
Recruiting
View on ClinicalTrials.gov →
Summary
Objectives: To identify differentially expressed miRNAs in the blood of adenomyosis patients in view to develop new diagnostic methods Hypotheses Circulating miRNAs may be abnormally expressed in patients suffering from adenomyosis and could be used to diagnose the disease Study Design Blood samples will be collected from healthy subjects and adenomyosis patients and miRNAs will be isolated and analyzed to detect potential differences.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-15.
Trial Details
NCT Number NCT06373822
Lead Sponsor Université Catholique de Louvain
Conditions Adenomyosis
Enrollment 50 participants
Start Date 2024-03-21
Primary Completion 2031-09 (estimated)
Study Completion 2031-09 (estimated)
Updated on ClinicalTrials.gov 2024-04-22